The excretion of ciprofloxacin in the small bowel was studied in 40 patients undergoing bowel surgery. Ciprofloxacin (200 mg) was administered iv, and intestinal samples were collected over a 120-min period. In ileal loops ciprofloxacin concentrations reached a peak of 4.0 mg/L, whereas in caecal fluid samples, concentrations were !0.16 mg/L. Ciprofloxacin administered directly into the ileal and caecal loops did not result in measurable blood levels for 2 h. The results confirm that ciprofloxacin is selectively excreted into the small bowel.
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Ciprofloxacin and several other fluoroquinolones are therapeutically effective in the treatment of some bacterial intestinal infections [1, 2] . We and others have demonstrated that in the isolated intestinal loop of the rabbit, in the isolated intestinal mucosa of the rabbit (in the Ussening chamber model), and in the human CaCO-2 cell layer, ciprofloxacin is transported from the blood into the intestinal lumen and from the serosal (i.e., baso-lateral) surface to the mucosal surfaces [3, 4] .
For the study described here, we enrolled 25 consecutive patients (20 men and 5 women; mean age ‫ע‬ SD, years; 63 ‫ע‬ 11 mean weight ‫ע‬ SD, kg) who underwent elective total 71 ‫ע‬ 17 or subtotal colectomy for colon cancer, and 15 patients (11 men and 4 women; mean age ‫ע‬ SD, years; mean 67 ‫ע‬ 8.5 weight ‫ע‬ SD, kg) who underwent bladder replacement 68 ‫ע‬ 15 operations for invasive bladder cancer. The following patients were excluded from the study: those who were aged !21 years; those who were allergic to fluoroquinolones; those who had other diseases that required any therapy; those who had received any antibiotic in the week before the study or who had an obvious infection at the beginning of the study; those who had serum creatinine levels 12.0 mg/dL, elevated liver enzyme levels (12 times normal values), hemoglobin levels !10 g/dL, and/or a WBC count !5000 cells/mm 3 , or any other evidence of distant metastases. Also excluded were patients who needed emergency surgery (for intestinal obstruction) and those who needed fluid resuscitation prior to surgery. All the patients who were enrolled were in reasonable state of health prior to the study. We excluded from the final analysis 2 patients who were found at surgery to have peritoneal metastases and 1 patient who had ascites.
Thirty-five of the 40 patients enrolled received, at different time points (during surgery, and after the isolation, clamping, and copious washing of a distal ileum or ascending colon segment), a single dose of ciprofloxacin (200 mg iv) over a 20 min period. In 4 of these patients a caecal loop was created in addition to the small bowel loop, and in 2 other patients both caecal and colonic loops were created. At different time points after the end of administration of ciprofloxacin (10, 15, 30, 60, and 120 min after), and without delaying the surgical procedure, intestinal fluid samples and blood samples were obtained for the ciprofloxacin assay. We planned that, for each time point, samples from 7 patients would be available for assay. The remaining 5 of the 40 patients received ciprofloxacin (200 mg) in 50 mL of physiologic saline, which was directly instilled into the ileal or colonic loop. Blood samples for the ciprofloxacin assay were obtained before the instillation and, starting immediately after the installation, every 15 min for 120 min.
Ciprofloxacin in serum was assayed as follows. The blood was allowed to clot, and serum samples were separated and frozen at -80ЊC. Protein was removed from the serum samples by use of a methanol solution containing ofloxacin (as an internal standard), and chromatography was done on a 20-mL sample. Intestinal fluid samples were frozen, lyophilized, and stored. Before the assay was performed, the samples were reconstituted with 1 ml of methanol-phosphoric acid (10 Ϫ1 M) mixture containing ofloxacin as an internal standard. After centrifugation (3000 rpm for 10 min; rotor size, 22 cm; Hezaeus Sepatech Megafuge), chromatography was done on 20 mL of this solution. Separation was done on a Novapack C 18 column (Millipore). The medium for the mobile phase was 25% methanol and 75% a mixture of heptane sulfonate, potassium dihydrogen phosphate, and triethylamine (pH 3.0). The flow rate was 1.5 mL/min, and spectrofluorimetric detection was done with the excitation level set at 330 nm, and the emission set at 440 nm. The sensitivity of the method was 0.06 mg/mL; its reproducibility was 83% and the coefficient of variance was 13.2% [5] . Ciprofloxacin concentrations could not be measured (concentration !0.05 mg/L) in the serum samples from the 5 patients who had been administered the drug directly into the terminal ileal loops or colonic segments. Ciprofloxacin concentrations were !0.16 mg/L in all caecal and colonic loop fluid samples from patients who received iv ciprofloxacin 10-25 min before the samples were obtained, whereas concentrations in serum samples obtained simultaneously with the fluid samples were 1.3-2.7 mg/L. In fluid samples obtained from terminal ileal loops, ciprofloxacin concentrations reached a peak level of 4.0 mg/L at 60 min, whereas peak levels in serum samples were 2.17 mg/L and were reached 15 min after the end of the drug infusion (figure 1).
Our data support previous observations that ciprofloxacin is excreted in the small bowel in humans [6] , resulting in levels of 251-811 mg/g in feces, and also confirm the results of studies of intestinal ciprofloxacin excretion in rabbit and rat models [3, 5] . All these observations underline that the small bowel, but not the caecum or the proximal colon, is an important route of excretion of ciprofloxacin and possibly other fluoroquinolones in mammals and humans. Because ciprofloxacin was not absorbed from these segments, the excretory process seems to have a unidirectional flow and is not simply a process of diffusion. These data also suggest that substantial reabsorption of ciprofloxacin does not occur in the distal ileum in humans. The intestinal excretory pathway of ciprofloxacin is of clinical relevance for the treatment of bacterial enteric infections, and for our understanding of alterations of the gut flora caused by ciprofloxacin [6] and the development of resistance to fluoroquinolones [2] .
